Terence Ching, PhD
Department of Psychiatry, Yale School of Medicine
Terence Ching (he/him) is a licensed clinical psychologist and associate research scientist in the Department of Psychiatry. Terence co-leads the development and conduct of psilocybin clinical trials for OCD as part of the Yale OCD Research Clinic, Emerging and Novel Applications for Consciousness-Altering Therapeutics (ENACT) Lab, and the Yale Program for Psychedelic Science. He has interests and expertise in: (1) fear-/trauma-based disorders; (2) exposure-based, integrative cognitive-behavior therapies; (3) culturally attuned care; and (4) therapeutic applications of psychedelics. Additionally, Terence is a MAPS-certified psychedelic therapist in the MDMA-Assisted Therapy for PTSD Expanded Access Program, and has experience providing ketamine-assisted therapy for patients with depression, anxiety, and PTSD.